Trump freeze on communications forces medical journal to pull HHS authors’ article

Taking stock of the drug industry, from the lab to the medicine chest

January 27, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

APStock STAT+ | 'This is censorship': Trump freeze on communications forces medical journal to pull HHS authors' article The paper on research integrity will have to be reviewed again, 'irrespective of what happened before the inauguration,' HHS told the journal By Ed Silverman STAT+ | Veru says its drug preserved lean mass in patients taking Wegovy The company said its drug enobosarm helped maintain patients' lean mass as they lost fat in a midstage trial, though more data are needed. By Elaine Chen STAT+ | Akero drug reverses liver scarring in study of severe MASH patients The performance of Akero's drug, called efruxifermin, in the severe MASH study outperformed investors' expectations. By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser